These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis. Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D. Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930 [Abstract] [Full Text] [Related]
28. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B, Kowalczyk JR, Chybicka A, Wachowiak J, Drabko K, Zaucha-Prazmo A, Choma M, Gorczyńska E, Toporski J, Turkiewicz D, Kałwak K, Pieczonka A, Boruczkowski D. Przegl Lek; 2004 Sep; 61 Suppl 2():53-6. PubMed ID: 15686047 [Abstract] [Full Text] [Related]
29. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas. Brice P, Marolleau JP, Dombret H, Lepage E, Baruchel A, Adam M, Miclea JM, Sitthy X, Gisselbrecht C. Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162 [Abstract] [Full Text] [Related]
30. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim. Damon L, Rugo H, Tolaney S, Navarro W, Martin T, Ries C, Case D, Ault K, Linker C. Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501 [Abstract] [Full Text] [Related]
31. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. Blystad AK, Delabie J, Kvaløy S, Holte H, Vålerhaugen H, Ikonomou I, Kvalheim G. Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376 [Abstract] [Full Text] [Related]
32. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ. Cancer; 2000 Aug 01; 89(3):680-9. PubMed ID: 10931469 [Abstract] [Full Text] [Related]
33. Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma. Mayer J, Vásová I, Korístek Z, Navrátil M, Klabusay M, Doubek M, Vorlícek J, Cernilová I, Vodvárka P, Petráková K. Eur J Haematol Suppl; 2001 Jul 01; 64():21-7. PubMed ID: 11486396 [Abstract] [Full Text] [Related]
34. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Alessandrino EP, Bernasconi P, Colombo A, Caldera D, Martinelli G, Vitulo P, Malcovati L, Nascimbene C, Varettoni M, Volpini E, Klersy C, Bernasconi C. Bone Marrow Transplant; 2000 Feb 01; 25(3):309-13. PubMed ID: 10673703 [Abstract] [Full Text] [Related]
39. Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis. Olivieri A, Brunori M, Capelli D, Montanari M, Massidda D, Gini G, Lucesole M, Poloni A, Offidani M, Candela M, Centurioni R, Leoni P. Eur J Haematol; 2004 Jan 01; 72(1):10-7. PubMed ID: 14962257 [Abstract] [Full Text] [Related]
40. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun 01; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]